StockMarketWire.com - Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 2240p (from 2300p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk